Interleukin-8 production by human airway epithelial cells in response to Pseudomonas aeruginosa clinical isolates expressing type a or type b flagellins

Clinical and Vaccine Immunology

Volumn 17, Issue 8, 2010, Pages 1196-1202

  Shanks, Kathleen K ^a   Guang, Wei ^a   Kim, K Chul ^b   Lillehoj, Erik P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; INTERLEUKIN 8; IL8 PROTEIN, HUMAN; ISOPROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; KERATITIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; RESPIRATORY EPITHELIUM; BIOSYNTHESIS; CELL LINE; CLASSIFICATION; EPITHELIUM CELL; IMMUNOBLOTTING; IMMUNOLOGY; RESPIRATORY TRACT MUCOSA; SECRETION (PROCESS);

CELL LINE; EPITHELIAL CELLS; FLAGELLIN; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-8; PROTEIN ISOFORMS; PSEUDOMONAS AERUGINOSA; RESPIRATORY MUCOSA;

EID: 77955295269     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00167-10     Document Type: Article

References (47)

1. Arora, S. K., M. C. Wolfgang, S. Lory, and R. Ramphal. 2004. Sequence polymorphism in the glycosylation island and flagellins of Pseudomonas aeruginosa. J. Bacteriol. 186:2115-2122.
2. Banks-Schlegel, S. P., A. F. Gazdar, and C. C. Harris. 1985. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines. Cancer Res. 45:1187-1197.
3. Bradford, M. M. 1976. A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-254.
4. Brimer, C. D., and T. C. Montie. 1998. Cloning and comparison of fliC genes and identification of glycosylation in the flagellin of Pseudomonas aeruginosa a-type strains. J. Bacteriol. 180:3209-3217.
5. Campodónico, V. L., N. J. Llosa, M. Grout, G. Döring, T. Maira-Litrán, and G. B. Pier. 2010. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infect. Immun. 78:746-755.
6. Carmeli, Y. 2008. Strategies for managing today's infections. Clin. Microbiol. Infect. 14:22-31.
7. Cozens, A. L., M. J. Yezzi, M. Yamaya, J. A. Wagner, D. Steiger, S. S. Garber, L. Chin, E. M. Simon, G. R. Cutting, P. Gardner, D. S. Friend, C. B. Basbaum, and D. C. Gruenert. 1992. A human transformed epithelial cell line that retains tight junctions. In Vitro Cell. Dev. Biol. 28:735-744.
8. Dean, T. P., Y. Daij, J. K. Shute, M. K. Church, and J. O. Warner. 1993. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr. Res. 34:159-161.
9. DiMango, E., H. J. Zar, R. Bryan, and A. Prince. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J. Clin. Invest. 96:2204-2210.
10. Döring, G., C. Meisner, and M. Stern. 2007. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 104:11020-11025.
11. Engel, J., and P. Balachandran. 2009. Role of Pseudomonas aeruginosa type III effectors in disease. Curr. Opin. Microbiol. 12:61-66.
12. Feldman, M., R. Bryan, S. Rajan, L. Scheffler, S. Brunnert, H. Tang, and A. Prince. 1998. Role of flagella in the pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 66:43-51.
13. Gewirtz, A. T., T. A. Navas, S. Lyons, P. J. Godowski, and J. L. Madara. 2001. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:1882-1885.
14. Giard, D. J., S. A. Aaronson, G. J. Todaro, P. Arnstein, J. H. Kersey, H. Dosik, and W. P. Parks. 1973. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51:1417-1423.
15. Harrison, L. M., P. Rallabhandi, J. Michalski, X. Zhou, S. R. Steyert, S. N. Vogel, and J. B. Kaper. 2008. Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-κB activation. Infect. Immun. 76:5524-5534.
16. Holder, I. A., R. Wheeler, and T. C. Montie. 1982. Flagellar preparations from Pseudomonas aeruginosa: animal protection studies. Infect. Immun. 35:276-280.
17. Huber, A. R., S. J. Kunkel, R. F. Todd, and S. J. Weiss. 1991. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99-102.
18. Jacchieri, S. G., R. Torquato, and R. R. Brentani. 2003. Structural study of binding of flagellin by Toll-like receptor 5. J. Bacteriol. 185:4243-4247.
19. Kelly-Wintenberg, K., T. Anderson, and T. C. Montie. 1990. Phosphorylated tyrosine in the flagellum filament protein of Pseudomonas aeruginosa. J. Bacteriol. 172:5135-5139.
20. Kelly-Wintenberg, K., S. L. South, and T. C. Montie. 1993. Tyrosine phosphate in a- and b-type flagellins of Pseudomonas aeruginosa. J. Bacteriol. 175:2458-2461.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Landsperger, W. J., K. D. Kelly-Wintenberg, T. C. Montie, L. S. Knight, M. B. Hansen, C. C. Huntenburg, and M. J. Schneidkraut. 1994. Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat. Infect. Immun. 62:4825-4830.
23. Lillehoj, E. P. 1994. Protein immunoblotting, p. 273-289. In V. S. Malik and E. P. Lillehoj (ed.), Antibody techniques. Academic Press, San Diego, CA.
24. Lu, W., A. Hisatsune, K. Kato, T. Koga, E. P. Lillehoj, W. Chen, A. S. Cross, S. J. Gendler, A. T. Gewirtz, and K. C. Kim. 2006. Enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice. J. Immunol. 176:3890-3894.
25. Luzar, M. A., M. J. Thomassen, and T. C. Montie. 1985. Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect. Immun. 50:577-582.
26. Mahenthiralingam, E., M. E. Campbell, and D. P. Speert. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62:596-605.
27. Mahenthiralingam, E., and D. P. Speert. 1995. Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum. Infect. Immun. 63:4519-4523.
28. Montie, T. C., R. C. Craven, and I. A. Holder. 1982. Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization. Infect. Immun. 35:281-288.
29. Montie, T. C., D. Doyle-Huntzinger, R. C. Craven, and I. A. Holder. 1982. Loss of virulence associated with the absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model. Infect. Immun. 38:1296-1298.
30. Morgan, J. A., N. F. Bellingham, C. Winstanley, M. A. Ousley, C. A. Hart, and J. R. Saunders. 1999. Comparison of flagellin genes from clinical and environmental Pseudomonas aeruginosa isolates. Appl. Environ. Microbiol. 65:1175-1179.
31. Nilsson, E., A. Amini, B. Wretlind, and A. Larsson. 2007. Pseudomonas aeruginosa infections are prevented in cystic fibrosis patients by avian antibodies binding to Pseudomonas aeruginosa flagellins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 856:75-80.
32. Oishi, K., F. Sonoda, A. Iwagaki, P. Ponglertnapagorn, K. Watanabe, T. Nagatake, A. Siadak, M. Pollack, and K. Matsumoto. 1993. Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia. Antimicrob. Agents Chemother. 37:164-170.
33. Prince, A. 2006. Flagellar activation of epithelial signaling. Am. J. Respir. Cell Mol. Biol. 34:548-551.
34. Reddel, R. R., Y. Ke, and B. I. Gerwin. 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 8:1904-1909.
35. Reed, K. A., M. E. Hobert, C. E. Kolenda, K. A. Sands, M. Rathman, M. O'Connor, S. Lyons, A. T. Gewirtz, P. J. Sansonetti, and J. L. Madara. 2002. The Salmonella typhimurium flagellar basal body protein FliE is required for flagellin production and to induce a proinflammatory response in epithelial cells. J. Biol. Chem. 277:13346-13353.
36. Ruimy, R., E. Genauzeau, C. Barnabe, A. Beaulieu, M. Tibayrenc, and A. Andremont. 2001. Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect. Immun. 69:584-588.
37. Saha, S., F. Takeshita, T. Matsuda, N. Jounai, K. Kobiyama, T. Matsumoto, S. Sasaki, A. Yoshida, K. Q. Xin, D. M. Klinman, S. Uematsu, K. J. Ishii, S. Akira, and K. Okuda. 2007. Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine. J. Immunol. 179:1147-1154.
38. Saiman, L., and A. Prince. 1993. Pseudomonas aeruginosa pili bind to asialoGM1, which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92:1875-1880.
39. Schirm, M., S. K. Arora, A. Verma, E. Vinogradov, P. Thibault, R. Ramphal, and S. M. Logan. 2004. Structural and genetic characterization of glycosylation of type a flagellin in Pseudomonas aeruginosa. J. Bacteriol. 186:2523-2531.
40. Schroeder, T. H., T. Zaidi, and G. B. Pier. 2001. Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM1 on epithelial cells. Infect. Immun. 69:719-729.
41. Smith, E. E., D. G. Buckley, Z. Wu, C. Saenphimachak, L. R. Hoffman, D. A. D'Argenio, S. I. Miller, B. W. Ramsey, D. P. Speert, S. M. Moskowitz, J. L. Burns, R. Kaul, and M. V. Olson. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103:8487-8492.
42. Starkey, S. D., and J. W. Chandler. 1975. Experimental keratitis due to Pseudomonas aeruginosa: model for evaluation of antimicrobial drugs. Antimicrob. Agents Chemother. 8:350-355.
43. Totten, P. A., and S. Lory. 1990. Characterization of the a-type flagellin gene from Pseudomonas aeruginosa PAK. J. Bacteriol. 172:7188-7199.
44. Verma, A., S. K. Arora, S. K. Kuravi, and R. Ramphal. 2005. Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect. Immun. 73:8237-8246.
45. Verma, A., M. Schirm, S. K. Arora, P. Thibault, S. M. Logan, and R. Ramphal. 2006. Glycosylation of b-type flagellin of Pseudomonas aeruginosa: structural and genetic basis. J. Bacteriol. 188:4395-4403.
46. Winstanley, C., S. B. Kaye, T. J. Neal, H. J. Chilton, S. Miksch, C. A. Hart, and the Microbiology Ophthalmic Group. 2005. Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J. Med. Microbiol. 54:519-526.
47. Zhang, J., K. Xu, B. Ambati, and F. S. Yu. 2003. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest. Ophthalmol. Vis. Sci. 44:4247-4254.